Dental devices include products used for diagnosis of dental ailments and for dental treatment such as oral prophylaxis, dental surgical and restorative procedures. Dental bone grafts and substitutes are used to augment or fill a defect created by surgery, trauma, disease, or developmental deficiency. GlobalData uses proprietary data and analytics to provide a comprehensive report on the dbgs and regenerative materials devices market, including market shares of different players within the US. Buy the latest report here.
In 2022, GlobalData’s Market Model methodology determined that the leading player in the dbgs and regenerative materials market in the US was Geistlich Pharma followed by Straumann, Dentsply Sirona, Zimmer Biomet, LifeNet Health and Dentium.
Bone grafts and regenerative materials regenerate the natural bone and dental tissue. Dental bone graft substitutes include dental bone grafts and synthetic dental bone graft substitutes. Synthetic dental bone graft substitutes are used for the treatment of a dental bone defect.
Following the widespread disruption resulting from the COVID-19 pandemic to the broader medical devices market during 2020 and 2021, the value of the dbgs and regenerative materials devices market within the US was expected to be over $200m in 2022.
For the latest complete market share analysis of dbgs and regenerative materials device market in the US, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.